Thu, Nov 20, 2014, 5:12 PM EST - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Neurocrine Biosciences Inc. Message Board

  • frogsleapmerlot frogsleapmerlot Dec 17, 2012 12:31 PM Flag

    Is NBIX going to be a 2013

    M&A Target??????????

    IMO,,,,,,, If UF P2 trials positive for E .. Abbott will take NBIX out for a nice premo price.
    Given Abbotts worldwide Womens health drug franchise its a no brainer.
    Give Kevy and the boys a nice pay day to play some serious Golf.

    frogs

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Abbott is going CANADIAN with a small but sizzling company calles APRI with
      an impressive list of medical novelties, the first FDA approved is also on the verge of
      getting the Canadian Govt approval.

      Heavyweight ABBOTT has made here a major pharmaceutical deal.
      It has signed (earley 2012) to become the official drug house to start a full introduction of APRI's
      novel drugs in Canada.A very clear indication of ABT's plans with APRI and Canada.

      It was developed by Apri on the premise that leading
      sex psychiatrists claim is the key to a truly satisfying sexual and personal bondage.

      This ASPRI drug should make 30% - 40% of women
      who at the moment cannot enjoy sex in marriage/friendship relations due to the
      constant lingering of these psychic side effects. The make believe that these women
      adopt always break down,causing tensions to get out of hand.
      This seems to be the major cause of this high percentige
      of women to need treatment.

      Children of these women are also likely to be affected- when time comes
      to go find a husband, she will also get good to
      make believe her passion is genuine.

      ABT has done their home work as usual.
      Apri has already started to negotiate with some of the larger
      European and Far Eastern Pharma Houses on taking this drug to market.
      Some deals have been made recently.

      At $ 2.00 APRI look inexpensive.

      Good luck to all .

      Lars

      Sentiment: Strong Buy

      • 1 Reply to b_lwa
      • I'm in APRI but it has been a terrible investment so far. The CEO was booted or quit, the drug Abbott is partnered on is delayed to market with no updates on launch timing and their focus is changing all the time. Now they don't even mention the specialty oncology products they spent so much on. Personally, I'd like to see someone buy that hunk of junk and set me free! Terrible terrible investment so far. My only hope is that someone buys them.

    • Endo phase 2's were already positive. You must be thinking about uterine fibroids?

 
NBIX
18.59-0.44(-2.31%)Nov 20 4:00 PMEST

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.